2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.
The progress of CLL research: towards targeted therapy
The differences between biological and chronological age, with their implications on AML treatment
Patient-physician communication: an important contributor to cancer care
Overview of 3 studies on CLL therapy: data on ibrutinib and a ROR1 inhibitor